ClinicalTrials.govpublic full text
Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function
subjects with mild cognitive impairment (mci) of ad, alzheimer's disease (ad) dementia, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877915
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.